Global
Remifentanil
Hydrochloride Market is expected to grow at a significant CAGR
in the upcoming years as the scope and its applications are increasing across
the globe. A potent ultra short-acting synthetic opioid analgesic drug is
referred to Remifentanil. It is given to patients in the course of surgery to
get rid of pain and as an adjunct to an aesthetic.
The
factors that propel the growth of the Remifentanil Hydrochloride Market include
increasing demand, rapid urbanization & industrialization, and product
development & technological innovations. On the other hand, there are also
factors that may hamper the growth of the market such as high cost.
Remifentanil Hydrochloride Industry is classified on the basis of product type,
applications, distribution channel and geography.
Remifentanil
Hydrochloride Market is segmented by product type as 1mg/Pcs, 2mg/Pcs, 5mg/Pcs
and others. The market is classified on applications as endotracheal intubation
operation, postoperative analgesia, neurosurgery, outpatient surgery, and
others. Remifentanil Hydrochloride Market is segmented by distribution channel
as online stores, specialty stores and others. The Industry is classified on
the basis of geography as North America, Latin America, Western Europe, Eastern
Europe, Asia Pacific, Japan and Middle East and Africa.
North
American region consists of the U.S., and Canada. Latin America region consists
of Mexico and Brazil. The Western European region consists of Germany, Italy,
France, England and Spain. The Eastern European region consists of Poland and
Russia. Asia Pacific region consists of China, India, ASEAN, and Australia
& New Zealand. The Middle East and African region consists of GCC, South
Africa and North Africa.
Market Segment:
Geographically, this report is segmented
into several key Regions, with production, consumption, revenue (million USD),
market share and growth rate of Remifentanil Hydrochloride in these regions,
from 2012 to 2022 (forecast), covering
•
North America
•
Europe
•
China
•
Japan
•
Southeast Asia
•
India
Global Remifentanil Hydrochloride market
competition by top manufacturers, with production, price, revenue (value) and
market share for each manufacturer; the top players including
•
GSK
•
Macfarlan Smith
•
Abbott
•
Mylan
•
Arevipharma
•
AMRI
Some
of the key players that fuel the growth of the Remifentanil Hydrochloride
Market include Abbott, AMRI, Arevipharma, GSK, Macfarlan Smith, Mylan, and
others. The key players are focusing on inorganic growth to sustain themselves amidst
fierce competition. As such, mergers, acquisitions, and joint ventures are the
need of the hour.
Comments
Post a Comment